NCT06190652Completed
Real-world Experience of ICIs Plus Chemotherapy With or Without Radiotherapy for Advanced ESCC.
Real-world Experience of Immunotherapy Plus Chemotherapy as First-line Treatment With or Without Radiotherapy for Patients With Advanced Oesophageal Squamous Cell Carcinoma in China
Source: ClinicalTrials.gov · Last updated 5 Feb 2024
Brief summary (registry, in English)
This study is a multi-center, non-interventional study. Clinicopathologic, treatment , outcome and efficacy data will be collected from medical records in metastatic esophageal squamous cell carcinoma (ESCC) patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 728 (actual)
- First submitted
- 19 Dec 2023
- Start date
- 13 Oct 2018
- Primary completion date
- 4 Dec 2023
- Lead sponsor
- Tianjin Medical University Cancer Institute and Hospital
- Diseases
- Gastric and esophageal cancer
- NCT number
- NCT06190652
What you commit to
- Study type: Observational
- Participants enrolled: 728
- From 13 Oct 2018 to the primary completion date, 4 Dec 2023
- 5 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Those who have a history of autoimmune disease or have been treated with immunosuppressants within the last 3 months.
- Those who have received organ transplant surgery.
Other illness
- Surgery for esophageal cancer;
- Risk of gastrointestinal bleeding, oesophageal fistula or oesophageal perforation
- Patients with a previous history of malignant tumor (skin basal cell carcinoma and cervical carcinoma in situ) survived tumor-free for 3 years after treatment.
- Except for the above).
- There are other serious diseases, such as myocardial infarction, cerebral infarction or severe cardiopulmonary insufficiency within 6 months
Other
- Esophageal fistulae due to infiltration of the primary tumour.
Who the study is looking for
- Pathologically diagnosed as esophageal squamous cell carcinoma;
- The clinical stage is IVb stage, that is, non-regional lymph node metastasis and distant organ metastasis (AJCC8th) of esophageal carcinoma.
- Patients had received no previous systemic therapy
- Patients who had received at least one cycle of first-line chemotherapy combined with immunotherapy, received or did not receive radiotherapy;
- Complete medical records;
- ECOG0-2;
Age in the registry: 18 years to 90 years · Sex: All · Does not accept healthy volunteers
Sites (5)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hunan Cancer Hospital Coordinator of this site? Confirm its status | Changsha | China | Unknown status |
| Sichuan Cancer Hospital Coordinator of this site? Confirm its status | Chengdu | China | Unknown status |
| Shanxi Cancer hospital Coordinator of this site? Confirm its status | Taiyuan | China | Unknown status |
| Tianjin Cancer Hospital Coordinator of this site? Confirm its status | Tianjin | China | Unknown status |
| Henan Cancer Hospital Coordinator of this site? Confirm its status | Zhengzhou | China | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.